SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 2430.
  • 2
    United Network for Organ Sharing. Components of the CTP score employed in the previous liver allocation policy. Available at: http://www.unos.org/. Accessed September 5, 2006.
  • 3
    Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000; 6: 543552.
  • 4
    Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academy Press; 1999: 5778.
  • 5
    Organ procurement and transplantation network-HRSA. Final rule with comment period. 63, 16 296-16 338. Fed Reg 1998.
  • 6
    Committee on Organ Procurement and Transplantation Policy. Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule 82. Washington, DC: National Academy Press; 1999.
  • 7
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864871.
  • 8
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 9
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 9196.
  • 10
    Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 715.
  • 11
    Freeman RB, Weisner RH, Harper A, McDairmid SV, Lake J, Edwards E B, et al. The New Liver Allocation System: moving towards evidence-based transplantation policy. Liver Transpl 2002; 8: 851858.
  • 12
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693699.
  • 13
    Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127: S261S267.
  • 14
    Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9: 684692.
  • 15
    Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10: A6A22.
  • 16
    Organ Procurement and Transplantation Network. Policies. Available at: http://www.optn.org/policiesAndBylaws/policies.asp. Accessed September 5, 2006.
  • 17
    Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005; 5: 22442247.